Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health, under the Department of Health and Human Services, has issued solicitation RFA-AI-27-014 to fund research focused on radiological, nuclear, and chemical public health emergencies. This opportunity seeks to advance the understanding of radiation and chemical exposure natural history, create relevant injury models, and validate diagnostic tools, biomarkers, and triage technologies. A primary goal of the funding is to support the development of effective medical countermeasures to treat or mitigate both acute and delayed injuries. This federal solicitation is open for responses until October 9, 2028. It is structured as a U01 grant, though clinical trials are not allowed under this specific notice. Interested parties can contact the National Institutes of Health for further information regarding the application process and technical requirements.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
